Good
Documentation Practices (GDP) in Pharmaceuticals
1. All documentation entries shall
be made with indelible black ink in clear and legible handwriting.
2. Verification of the Document
made by QA by using indelible blue ink.
3. Green ink shall be used only by
QA for issuance of BMR / BPR.
4. Do not leave any column in the
record / document unfilled. If any column in a record document is not applicable, write “N.A”. If no comments
write nil or put ‘---‘.
5. Time should be expressed as
HH.MM i.e. 2 pm should be recorded as 14.00 hrs.
6. While issuing documents and in
other record books the date should expressed as DD-MM-YY or DD.MM.YY or DD/MM/YY.
7. While approving document the
date should be expressed as DD-MM-YYYY or DD.MM.YYYY or DD/MM/YYYY.
8. If any page(s) left blank, draw
a line across the page from left top to right bottom of the page and write
“CANCELLED” / “N.A.” (Not applicable) across the page and sign with date.
9. If an entire page / paragraph
is to be cancelled from a document, QA counter sign is required.
10. No pencil entries are allowed.
11. Do not use correction fluid in
any of the documents
12. All personnel shall avoid
errors during data entry.
13. In case an entry error is
occurred, the same shall be corrected as described below.
14. Do not overwrite the wrong
entries. Cross it out with a line permitting the reading of original entry.
Clearly write the correct entry near the cross out.
15. Initial / Sign and put date,
on which the correction was made. Wherever appropriate, the reasons for
correction shall be recorded.
16. If the correction is made on a
date after the date of original entry, it must be corrected as mentioned above
and counter signed and dated by the supervisor or QA.
17. If an entire line / paragraph
/ page to be deleted from a sequential record (e.g. log book or stock card) the
following steps to be taken.
i) Cross out with a line
ii) Write a comment explaining the
reason for deletion near the cross out.
iii) Initial / sign and put the
date, on which the correction was made.
No comments:
Post a Comment